[1]余情瑶,徐英.老年心力衰竭合并衰弱的发生现状及研究进展[J].国际心血管病杂志,2024,01:34-36,44.
点击复制
老年心力衰竭合并衰弱的发生现状及研究进展(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2024年01期
- 页码:
- 34-36,44
- 栏目:
- 综述
- 出版日期:
- 2024-01-22
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2024.01.010
- 文献标识码:
- -
- 摘要:
- 心力衰竭是临床常见的心脏功能障碍疾病，多发于老年群体，具有较高的发病 率、再住院率及死亡率。衰弱是机体脆弱性增加、生理储备、应激反应及自身稳态能力下 降的身体机能状态。老年心力衰竭患者合并衰弱的发生率逐年增加，并对老年人的健康和生 活质量造成严重影响。该文介绍老年心力衰竭合并衰弱的发生、病因、临床表现、诊治及 预防等研究进展。
- Abstract:
- -
参考文献/References
[1] Maack C. Mechano-energetic defects in heart failure[J]. Herz,
2023, 48(2):123-133.
[2] Narasimmaraj PR, Wadhera RK. Heart failure readmissions: a
measure of quality or social vulnerability?[J]. JACC Heart Fail,
2023, 11(1):124-125.
[3] Alattas A, Nikolova S, Shuweihdi F, et al. The impact of longterm
conditions on the progression of frailty[J]. PLoS One, 2023,
18(4):e0284011.
[4] Chao CT, Hung KY. Vascular frailty, a proposal for new
frailty type: a narrative review[J]. Kaohsiung J Med Sci, 2023,
39(4):318-325.
[5] Boureau AS, Annweiler C, Belmin J, et al. Practical management
of frailty in older patients with heart failure: statement from a
panel of multidisciplinary experts on behalf the Heart Failure
Working Group of the French Society of Cardiology and on
behalf French Society of Geriatrics and Gerontology[J]. ESC
Heart Fail, 2022, 9(6):4053-4063.
[6] Jujo K, Kagiyama N, Saito K, et al. Impact of social frailty in
hospitalized elderly patients with heart failure: a FRAGILE-HF
registry subanalysis[J]. J Am Heart Assoc, 2021, 10(17):e019954.
[7] Saitoh M, Takahashi Y, Okamura D, et al. Prognostic impact
of hospital-acquired disability in elderly patients with heart
failure[J]. ESC Heart Fail, 2021, 8(3):1767-1774.
[8] Sze S, Pellicori P, Zhang J, et al. Effect of frailty on treatment,
hospitalisation and death in patients with chronic heart failure[J].
Clin Res Cardiol, 2021, 110(8):1249-1258.
[9] Sundquist K, Sundquist J, Wang X, et al. Baseline mitochondrial
DNA copy number and heart failure incidence and its role in
overall and heart failure mortality in middle-aged women[J].
Frontiers in cardiovascular medicine, 2022, 9:1012403.
[10] Uchmanowicz I, Nessler J, Gobbens R, et al. Coexisting frailty
with heart failure[J]. Front Physiol, 2019, 10: 791.
[11] Parish AL. Degenerative or debilitative neurologic syndromes[J].
Nurs Clin North Am, 2018, 53(3):447-457.
[12] Pacho C, Domingo M, Nú?ez R, et al. Predictive biomarkers for
death and rehospitalization in comorbid frail elderly heart failure
patients[J]. BMC Geriatr, 2018, 18(1):109.
[13] Pandey A, Kitzman D, Reeves G. Frailty is intertwined with
heart failure: mechanisms, prevalence, prognosis, assessment,
and management[J]. JACC Heart Fail, 2019, 7(12):1001-1011.
[14] Vitale C, Jankowska E, Hill L, et al. Heart Failure Association/
European Society of Cardiology position paper on frailty in patients
with heart failure[J]. Eur J Heart Fail, 2019, 21(11):1299-1305.
[15] Uchmanowicz I, Lee CS, Vitale C, et al. Frailty and the risk of
all-cause mortality and hospitalization in chronic heart failure: a
meta-analysis[J]. ESC Heart Fail, 2020, 7(6):3427-3437.
[16] Chen XZ, Hou CL, Yao L, et al. The association between chronic
heart failure and frailty index: a study based on the National
Health and Nutrition Examination Survey from 1999 to 2018[J].
Front Cardiovasc Med, 2022, 9:1057587.
[17] Uchikado Y, Ikeda Y, Ohishi M. Current understanding of the role
of frailty in cardiovascular disease[J]. Circ J, 2020, 84(11):1903-
1908.
[18] Kanenawa KJ, Isotani A, Yamaji K, et al. The impact of frailty
according to Clinical Frailty Scale on clinical outcome in patients
with heart failure[J]. ESC Heart Fail, 2021, 8(2):1552-1561.
[19] Charkiewicz M, Wojszel ZB, Kasiukiewicz A, et al. Association
of chronic heart failure with frailty, malnutrition, and sarcopenia
parameters in older patients—a cross-sectional study in a
geriatric ward[J]. J Clin Med, 2023, 12(6):2305.
[20] Lee KS, Noh J, Park SM, et al. Evaluation and management
of patients with diabetes and heart failure: a korean diabetes
association and korean society of heart failure consensus
statement[J]. Diabetes Metab J, 2023, 47(1):10-26.
[21] Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults:
assessment, management, and challenges[J]. Clin Cardiol, 2020,
43(2):99-107.
[22] Zheng PP, Yao SM, He W, et al. Frailty related all-cause mortality
or hospital readmission among adults aged 65 and older with
stage-B heart failure inpatients[J]. BMC Geriatr, 2021, 21(1):125.
[23] Beltrami M, Fumagalli C, Frailty M. Sarcopenia and cachexia
in heart failure patients: different clinical entities of the same
painting[J]. World J Cardiol, 2021, 13(1):1-10.
[24] Schindler TH, Valenta I, Dilsizian V. Disturbances in brain-heart
neuronal-metabolic axis are associated with major arrhythmic
events in heart failure[J]. J Am Coll Cardiol, 2022, 80(20):1897-
1899.
[25] Li H, Xia YY, Xia CL, et al. Mimicking metabolic disturbance
in establishing animal models of heart failure with preserved
ejection fraction[J]. Front Physiol, 2022, 13:879214.
[26] 刘佳宝, 张瑞英. 心力衰竭时氧化应激与心肌代谢[J]. 国际心
血管病杂志, 2022, 49(2):89-91.
[27] Liperoti R, Vetrano DL, Palmer K, et al. Association between
frailty and ischemic heart disease: a systematic review and metaanalysis[
J]. BMC Geriatr, 2021, 21(1):357.
[28] 中华医学会心血管病学分会心力衰竭学组, 中国医师协会
心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国
心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018,
46(10):760-789.
[29] 韩君, 王君俏, 谢博钦, 等. Fried衰弱表型和FRAIL量表及埃德
蒙顿衰弱评估量表在社区高龄老年人衰弱筛查中一致性和适
用性的比较研究[J]. 中国全科医学, 2021, 24(21):2669-2675.
[30] Sze S, Pellicori P, Zhang JF, et al. Identification of frailty in
chronic heart failure[J]. JACC Heart Fail, 2019, 7(4):291-302.
[31] Grundmann S. von Zur mühlen C. European guidelines on heart
failure: pharmacotherapy[J]. Herz, 2023, 48(2):89-94.
[32] Pandey A, Gilbert O, Kitzman DW. Physical frailty in older
patients with acute heart failure: from risk marker to modifiable
treatment target[J]. J Am Geriatr Soc, 2021, 69(9):2451-2454.
[33] Becher PM, Seiffert M. Interventional treatment of heart failure:
stents and valves[J]. Herz, 2023, 48(2):101-108.
[34] Wang KY, Sun XQ, Sun Y, et al. Transcriptional regulation of
macrophages in heart failure[J]. Front Cardiovasc Med, 2023,
10:1148041.
[35] Daubert MA, Douglas PS. Primary prevention of heart failure in
women[J]. JACC Heart Fail, 2019, 7(3):181-191.
[36] Kocagoncu E, Nesbitt D, Emery T, et al. Neurophysiological
and brain structural markers of cognitive frailty differ from
alzheimer's disease[J]. J Neurosci, 2022, 42(7):1362-1373.
[37] Marinus N, Vigorito C, Giallauria F, et al. Frailty test battery
development including physical, socio-psychological and
cognitive domains for cardiovascular disease patients: a
preliminary study[J]. J Clin Med, 2022, 11(7):1926.
[38] Ijaz N, Buta B, Xue QL, et al. Interventions for frailty among
older adults with cardiovascular disease: JACC state-of-the-art
review[J]. J Am Coll Cardiol, 2022, 79(5):482-503.
[39] Irabor B, McMillan JM, Fine NM. Assessment and management
of older patients with transthyretin amyloidosis cardiomyopathy:
geriatric cardiology, frailty assessment and beyond[J]. Front
Cardiovasc Med, 2022, 9:863179.
备注/Memo
- 备注/Memo:
- 通信作者：徐英， E-mail：1419850448@qq.com
常用功能
统计/Statistics
- 摘要浏览/Viewed137
- 全文下载/Downloads525
- 评论/Comments
